Press Releases

Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries

Yourgene’s LightBench instrument offers precise and accurate target enrichment of PacBio HiFi SMRTbell sequencing libraries increasing HiFi sequencing yields

Manchester, UK, 16 November 2023: Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, and PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration to optimise size selection for long-read sequencing workflows. PacBio has qualified Yourgene’s LightBench® instrument for the size selection of long DNA fragments, enabling high yields for HiFi sequencing data.

Yourgene Health installs first NIPT platform, the IONA test, in Morrocco, enabling Laboriad to offer safe, fast and accurate prenatal testing to expectant parents

Manchester, UK, and Rabat, MOROCCO, 09 November 2023: Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, has installed the first non-invasive prenatal testing (NIPT) workflow in Morocco based on the IONA® test at the Centre de Biologie Riad (Laboriad). By offering this service locally, Laboriad can broaden its offering and provide pregnant women fast, reliable results that reduce the need for invasive tests and the associated stress and anxiety for expectant parents.

IVDR certification achieved for DPYD genotyping assay

First product of its kind to conform with new IVDR requirements

Yourgene Health (part of the Novacyt group), an international specialist in clinical diagnostics, confirms – IVDR accreditation under the new requirements of the In Vitro Diagnostic Regulation (“IVDR”) for its DPYD genotyping assay, which helps identify cancer patients at risk of suffering a severe, and potentially life-threatening, reaction to common chemotherapy.

Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows

Offers clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and reagents for Yourgene’s Sage 32 NIPT Workflow

Manchester, UK, and SINGAPORE, 5 September 2023: Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, today launched the Yourgene® MagBench™ Automated DNA Extraction Instrument and Kit.

The collaborative study with Tommy’s Charity and St Mary’s NHS Hospital (Manchester, UK) used Yourgene’s IONA® Nx NIPT Workflow, a fully validated clinical workflow which utilises NGS to estimate the trisomy risk in the fetus.

Yourgene announces the reappointment of Dr. Joanne Mason, Chief Scientific Officer, as a Director of the Company with immediate effect.

Yourgene has entered into an agreement via its subsidiary Concepta Diagnostics Limited with Boots UK Limited (“Boots”), the health and beauty retailer and pharmacy group, to launch its extended range of at-home self-testing products tests via boots.com and across 120 Boots stores in Great Britain and Northern Ireland.

Andy Leeser is one of the UK’s most experienced mid-market corporate transformation specialists. He has been involved with a range of transformation projects and transactions, including refinancings and equity/ asset sales across the Automotive, Oil and Gas, Brewing, Retail and Telecommunications sectors.

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) DHSC contract awarded to support COVID-19 Winter surge testingThird contract awarded under PHE National Microbiology Framework Agreement Manchester, UK – 23 December 2021: Yourgene (AIM: YGEN), a leading...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) H1 revenues doubled year-on-yearFull year revenues to exceed already upgraded market expectations Manchester, UK – 14 December 2021: Yourgene (AIM: YGEN), a leading integrated technologies and service...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) UKHSA contract awardContract for the provision of the genetic sequencing services Manchester, UK – 14 December 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces...

Yourgene Health plc(“Yourgene” or the “Company”) DPYD screening recommended in SpainFollows recommendations in Germany, Wales, England and Belgium Manchester, UK – 18 November 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, welcomes...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Yourgene’s Ranger® Technology to be presented at Labroots webinar Manchester, UK – 28 October 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that its Ranger®...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Half-year Trading updateImproved H1 and year-to-date performance supporting higher full-year expectations Manchester, UK – 26 October 2021: Yourgene (AIM: YGEN), a leading international molecular...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Further National Microbiology Framework contract award Successful tender under Lot 4 (Clinical Laboratory Diagnostic Testing Services) valued at £15bn Manchester, UK – 19 April 2021: Yourgene (AIM:...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) AGM StatementInvestor presentation Manchester, UK - 28 September 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, will be holding its Annual General Meeting (AGM)...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Further re: DHSC contract secured to support COVID-19 surge testing Manchester, UK 10 September 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, announces that a Contract...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Notice of AGM and Annual Report 2021Investor presentation Manchester, UK 1 September 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, announces that the Notice of Annual...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Yourgene Genomic Services receive ISO 15189:2012 accreditation Validating its COVID-19 testing and sequencing services, providing assurance of compliance to international standards to deliver quality...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Yourgene’s COVID-19 testing investment reaps rewardsDHSC contract secured to support COVID-19 surge testing Manchester, UK 19 August 2021: Yourgene (AIM: YGEN), a leading international molecular...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Audited Final results and unaudited Q1 business update Manchester, UK – 11 August 2021: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces its full year financial results for...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Earn-out Milestone, Issue of Equity & Total Voting Rights Manchester, UK 11 August 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, announces an issue of equity...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Second Strategic Partner for Coastal Genomics Manchester, UK – 21 June 2021: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that Yourgene Health Inc., the Company’s...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Contract Award for the supply of DPYD testing kits to NHS WalesEstimated to be worth £232,000 across two years   Manchester, UK –  June 2021: Yourgene (AIM: YGEN), the international molecular...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Multi-year licence and supply agreement with leading US precision medicine company Manchester, UK – 9 June 2021: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces it has...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Distribution Partnership for the Middle East and AfricaYourgene and Alliance Global launch partnership across multiple territories Manchester, UK – 19 May 2021: Yourgene (AIM: YGEN), the international...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Launch of IONA® Care NIPT service offeringExtended clinical menu to screen SCAs and AAs for pregnant women Manchester, UK – 18 May 2021: Yourgene (AIM: YGEN), the international molecular diagnostics...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Yourgene Genomic Services to support MHC’s second Boots agreement for Day 2 & Day 8 testingfor international arrivals to the UK  Manchester, UK – 17 May 2021: Yourgene (AIM: YGEN), the...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) COVID-19 update: approved provider for UK Government and response to new virus strain Manchester, UK – 24 December 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group,...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Half-year Report Manchester, UK – 17 December 2020: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services, announces its...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) DPYD kits recommended by NHS England Manchester, UK – 2 December 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, welcomes the Clinical Commissioning Urgent Policy Statement,...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Directorate changeChief Scientific Officer appointment to drive new product development roadmap Manchester, UK – 5 November 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group,...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Partnership with Take2 Health LimitedYourgene to run genomic test for Nasopharyngeal Carcinoma (NPC) Screening in Taiwan Manchester, UK – 3 November 2020: Yourgene (AIM: YGEN), the international...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Half-year Trading updateH1 year-on-year growth demonstrating the resilience of the Company Manchester, UK – 26 October 2020: Yourgene (AIM: YGEN), a leading international molecular diagnostics group,...

Yourgene Health plc(“Yourgene Health” or the "Company") CQC registration Manchester, UK – 23 October 2020: Yourgene Health (AIM: YGEN), a leading international molecular diagnostics group, announces that it has received notification from the Care Quality Commission...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Yourgene Genomic Services collaboration with Cytox Partnership with Cytox to enable clinical access to genoSCORE™ - a new genetic test to determine the risk of developing Alzheimer’s disease Manchester,...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Medilink Award win for Outstanding Achievement Manchester, UK – 14 February 2020:Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces it has won the Outstanding...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Elucigene DPYD tests to be used routinely in Wales Wales is first UK nation to offer DPYD screening to patients undergoing chemotherapyDPYD tests screen patients to identify risk of severe side effects...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Strategic reproductive health partnership secured in Japan Manchester, UK – 8 October 2020: Yourgene Health (AIM: YGEN), a leading international molecular diagnostics group, announces it has entered into...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) IONA® Nx awarded contract with St George’s NHS Hospital Manchester, UK – 7 October 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that it has been awarded the...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) CE-IVD Mark for Clarigene™ SARS-CoV-2 test Manchester, UK – 3 August 2020: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that it has achieved CE-IVD marking for its...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Launch of Yourgene Genomic Services Manchester, UK – 28 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces the launch of Yourgene Genomic Services, an...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) DPD reimbursement in Germany Manchester, UK – 24 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that the German Federal Joint Committee, G-BA, the national...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) AGM Statement Manchester, UK – 22 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, will be holding its Annual General Meeting (AGM) at 4:00pm today. At the meeting,...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) US distribution agreement for DPYD and other products Manchester, UK – 21 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that it has appointed...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) IONA® Nx Launch Manchester, UK – 3 September 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces the launch of IONA® Nx NIPT workflow, the Company’s new innovative...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) TGA approves IONA® Nx for sale in Australia Manchester, UK – 13 August 2020: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that its IONA® Nx NIPT workflow (‘IONA®...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Successful £16.15 million Placing & Close of Accelerated Bookbuild Manchester, UK – 5 August 2020: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group, is pleased to...

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.  Yourgene Health plc  (“Yourgene”, the “Company” or the “Group”)  Half-year Report  Manchester, UK – 2 December 2019: Yourgene Health plc (AIM:...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Bionow Double Award Wins Manchester, UK – 29 November 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces it has won Bionow Investment Deal of Year and Bionow...

Yourgene Health plc (“Yourgene” or the “Group” or the “Company”) Opening of New Facilities and Corporate HQ  Manchester, UK – 28 November 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces the official opening of its...

Yourgene Health plc(“Yourgene” or the “Group” or the “Company”) Launch of Yourgene Flex™ Analysis Software Manchester, UK 31 October 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces it has launched Yourgene Flex™ Analysis...

Yourgene Health plc (“Yourgene” or the “Group”) American Society of Human Genetics Annual Meeting attendance Manchester, UK – 15 October 2019:Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that it will be exhibiting at the...

Yourgene Health plc (“Yourgene” or the “Group”) Half year trading update Manchester, UK – 14 October 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, provides a positive trading update for the six months to 30 September 2019....

CE-IVD Certification renewal Manchester, UK – 26 September 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that in preparation for a 2020 product launch and as a contingency for BREXIT, the Company has successfully...

Yourgene Health plc (“Yourgene” or the “Company”) Launch of DPYD chemotoxicity diagnostic assay Test to identify cancer patients at risk of lethal side effects from chemotherapy Manchester, UK – 18 September 2019: Yourgene (AIM: YGEN), a leading international...

Yourgene Health plc (“Yourgene” or the “Company”) Notice of AGM Manchester, UK – 20 August 2019: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that its Annual General Meeting (AGM) will be held at 4:00pm on 17 September 2019 at...

Yourgene Health plc (“Yourgene” or the “Company”) Directorate Change Appointment of business development sector specialist as Non-executive Director  Manchester, UK – 16 August 2019:Yourgene (AIM: YGEN), a leading international molecular diagnostics group,...

Yourgene Health plc (“Yourgene”, the “Company” or the “Group”) Appointment of Director Manchester, UK – 29 July 2019: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services, announces the...

Yourgene Health plc (“Yourgene” or the “Company” or the “Group”) Results for the Year Ended 31 March 2019, Business Update and Director Change  Manchester, UK – 10 July 2019: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group which...

Yourgene Health plc(“Yourgene” or the “Company” or the “Group”) Results for the Year Ended 31 March 2019, Business Update and Director Change Manchester, UK – 10 July 2019: Yourgene Health plc (AIM: YGEN), the international...

Yourgene Health plc(“Yourgene Health” or the "Company") Yourgene participates in key global conferences Manchester, UK - 24 June 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services,...

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS RESTRICTED AND IS NOT FOR PUBLIC RELEASE, PUBLICATION, OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY...

Yourgene Health plc(“Yourgene” or the “Company”) Proposed acquisition of Delta Diagnostics (UK) Limited ("Elucigene")andProposed placing of a minimum of 92,682,928new Ordinary SharesandProposed subscription for 4,878,048new Ordinary Shares Highlights ● Proposed...

Yourgene Health plc (“Yourgene”, the “Company” or the “Group”) Full-year Trading Update Manchester, UK – 8 April 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services, announces a trading...

Yourgene Health plc (“Yourgene” or the “Company”) Yourgene raises IONA® test awareness in Egypt with British Ambassador Manchester, UK – 25 March 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and...

Yourgene Health plc (“Yourgene” or the “Company”) Yourgene Health Announces Capital and Commercial Restructuring with Major Shareholder Manchester, UK – 18 February 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group which commercialises...

Yourgene Health plc (“Yourgene”, the “Company”)   Yourgene launches Sage™ 32 plex   High throughput NIPT solution for clinical laboratories   Manchester, UK – 8 January 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group...